semglee vs semaglutide was just FDA approved as the FIRST biosimilar interchangeable insulin! It is now recognized as a biosimilar to Lantus! 💊 What does this mean? A biosimilar is a product that has PDF) Once‐weekly semaglutide versus insulin

However, there is limited real-world evidence comparing the effects of once-weekly (OW) GLP-1 RAs and dipeptidyl peptidase-4 inhibitors (DPP-4is)

Effectiveness In a controlled clinical trial, tirzepatide led to 20% reduction in body weight over a 72-week period

The difference in comfort between 29G and 30G is real but subtle

However, more long-term studies are needed

The decision to include seven participants was based on practical considerations and the standard practices for similar studies in sports science, particularly when measuring physiological variables like heart rate, respiratory quotient, and perceived exertion, which require high-quality, individualized data

GLP-1 receptor agonists like semaglutide and tirzepatide target the underlying metabolic drivers of weight gain: they reduce appetite signals in the brain, slow digestion so you stay full longer, improve insulin sensitivity, and reduce the hormonal hunger signals that make sustained dieting so difficult